Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
- Autores
- Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.
- Año de publicación
- 2013
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way.
Fil: Ramirez, Maria Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones En Microbiología y Parasitología Médica; Argentina. California State University. College Of Natural Science And Mathematics; Estados Unidos
Fil: Nikolaidis, N.. California State University. College Of Natural Science And Mathematics; Estados Unidos
Fil: Tolmasky, M.. California State University. College Of Natural Science And Mathematics; Estados Unidos - Materia
-
AMINOGLUCOSIDOS
ACETILTRANSFERASA
RESISTENCIA ANTIBIOTICA - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/8396
Ver los metadatos del registro completo
id |
CONICETDig_3b7c00cd54e43c9bd4624386f60b8115 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/8396 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigmRamirez, Maria SoledadNikolaidis, N.Tolmasky, M.AMINOGLUCOSIDOSACETILTRANSFERASARESISTENCIA ANTIBIOTICAhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way.Fil: Ramirez, Maria Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones En Microbiología y Parasitología Médica; Argentina. California State University. College Of Natural Science And Mathematics; Estados UnidosFil: Nikolaidis, N.. California State University. College Of Natural Science And Mathematics; Estados UnidosFil: Tolmasky, M.. California State University. College Of Natural Science And Mathematics; Estados UnidosFrontiers2013-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/8396Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.; Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm; Frontiers; Frontiers in Microbiology; 4; 5-2013; 1-131664-302Xenginfo:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fmicb.2013.00121/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2013.00121info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656343/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:53:54Zoai:ri.conicet.gov.ar:11336/8396instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:53:54.699CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm |
title |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm |
spellingShingle |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm Ramirez, Maria Soledad AMINOGLUCOSIDOS ACETILTRANSFERASA RESISTENCIA ANTIBIOTICA |
title_short |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm |
title_full |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm |
title_fullStr |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm |
title_full_unstemmed |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm |
title_sort |
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm |
dc.creator.none.fl_str_mv |
Ramirez, Maria Soledad Nikolaidis, N. Tolmasky, M. |
author |
Ramirez, Maria Soledad |
author_facet |
Ramirez, Maria Soledad Nikolaidis, N. Tolmasky, M. |
author_role |
author |
author2 |
Nikolaidis, N. Tolmasky, M. |
author2_role |
author author |
dc.subject.none.fl_str_mv |
AMINOGLUCOSIDOS ACETILTRANSFERASA RESISTENCIA ANTIBIOTICA |
topic |
AMINOGLUCOSIDOS ACETILTRANSFERASA RESISTENCIA ANTIBIOTICA |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way. Fil: Ramirez, Maria Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones En Microbiología y Parasitología Médica; Argentina. California State University. College Of Natural Science And Mathematics; Estados Unidos Fil: Nikolaidis, N.. California State University. College Of Natural Science And Mathematics; Estados Unidos Fil: Tolmasky, M.. California State University. College Of Natural Science And Mathematics; Estados Unidos |
description |
Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/8396 Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.; Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm; Frontiers; Frontiers in Microbiology; 4; 5-2013; 1-13 1664-302X |
url |
http://hdl.handle.net/11336/8396 |
identifier_str_mv |
Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.; Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm; Frontiers; Frontiers in Microbiology; 4; 5-2013; 1-13 1664-302X |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fmicb.2013.00121/full info:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2013.00121 info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656343/ |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers |
publisher.none.fl_str_mv |
Frontiers |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269256007286784 |
score |
13.13397 |